Update on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer Meeting Abstract
| Authors: | Smyth, L. M.; Saura, C.; Piha-Paul, S. A.; Lu, J.; Mayer, I. A.; Brufksy, A. M.; Spanggaard, I.; Arnedos, M.; Cutler, R. E.; Hyman, D. M. |
| Abstract Title: | Update on the phase II SUMMIT trial: Neratinib + fulvestrant for HER2-mutant, HR-positive, metastatic breast cancer |
| Meeting Title: | ESMO Breast Cancer 2019 |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2019 May 2-4 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-05-01 |
| Start Page: | mdz095.029 |
| Language: | English |
| ACCESSION: | WOS:000478092400031 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz095.029 |
| Notes: | Meeting Abstract: 30P -- Appears on pages iii10-iii11 of the abstract book -- Source: Wos |
